A comprehensive medical resource for parents exploring growth evaluation and treatment options. Our board-certified pediatric specialists provide personalized, private care for children who aren't reaching their height potential.
Children grow at predictable rates during different stages of development. Falling consistently below these benchmarks may indicate an underlying condition.
Growth hormone (somatotropin) is produced by the pituitary gland, a pea-sized structure at the base of the brain. It is released in pulses throughout the day, primarily during deep sleep and plays a critical role in childhood growth and development.
The earlier treatment begins, the greater the cumulative height gain — a finding consistently supported by four decades of registry data.— pediatric growth specialist community consensus
Growth hormone stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1), which directly drives the growth of cartilage cells in the growth plates (epiphyseal plates) of long bones. This process is what adds height during childhood and adolescence.
Some children produce insufficient growth hormone, leading to slower-than-normal growth rates. Others may produce adequate hormone but their bodies don't respond efficiently. In both cases, medically supervised growth hormone therapy can restore normal growth velocity and help children reach their full height potential.
Growth hormone therapy is medically indicated for several well-defined pediatric conditions, each diagnosed through specific testing protocols.
Insufficient production of growth hormone by the pituitary gland, confirmed through stimulation testing. The most common indication for therapy, with excellent response rates when treated early.
Children who are significantly shorter than peers (below the 1.2nd percentile) without an identifiable underlying cause. Growth hormone therapy can meaningfully improve adult height outcomes.
Children born significantly smaller than expected who fail to catch up in height by age 2-4. Early intervention with growth hormone can help these children reach normal height ranges.
A chromosomal condition affecting girls that results in short stature. Growth hormone therapy, often started early, can add significant height and improve developmental outcomes.
A genetic condition causing growth failure and other metabolic issues. Growth hormone therapy improves height, body composition, muscle tone and overall physical development.
Children with kidney disease often experience growth failure. Growth hormone therapy can help maintain normal growth velocity despite the underlying condition.
Growth plates (epiphyseal plates) are areas of developing cartilage at the ends of long bones. They are responsible for all longitudinal bone growth. Once these plates fuse and harden into solid bone, no medication, therapy, or treatment can add inches to height.
Children who begin growth hormone therapy at younger ages have more years of open growth plates and consistently achieve better height outcomes. Every year of delay narrows the treatment window and reduces potential height gain.
Growth plates typically close between ages 14-16 for girls and 16-18 for boys. Once closed, the opportunity is gone permanently. If your child is falling behind in height, the time to act is now.
Maximum treatment duration available. Children started in this range achieve the greatest height gains. Growth plates are fully open with years of growth potential remaining.
Significant height gains are still achievable. Growth plates are open but the treatment window is narrowing. Evaluation should happen promptly to maximize remaining growth potential.
Growth plates begin fusing. Treatment may still help but outcomes are limited. For girls, plates may close as early as 14. For boys, closure typically occurs by 16-18. Once fused, height is final.
Growth hormone therapy follows a structured protocol designed for safety, effectiveness and your child's comfort.
Most children are now on a the therapy schedule your physician recommends using modern pen devices at home. Weekly formulations have made treatment far more convenient for families. Daily options are also available depending on the protocol.
Today's auto-injector pen devices use ultra-fine needles that are virtually painless. With once-weekly dosing, most children adapt easily. Parents receive thorough training on proper technique and storage.
Check-ups every 3-6 months to track growth velocity, adjust dosing and monitor labs including IGF-1 levels and metabolic markers.
Treatment continues until target height is reached or growth plates begin closing. Consistent therapy yields the best long-term results.
Our partner practices operate as boutique, cash-pay clinics offering direct physician access, premium protocols and complete cost transparency.
Cash-pay only. No insurance accepted. This allows us to provide personalized protocols without insurance-driven restrictions. HSA and FSA accounts are accepted.
Answers to the questions we hear most from families considering growth hormone therapy.
Take the first step toward understanding your child's growth potential. Our team will contact you within 24 hours to arrange a confidential evaluation.
Your consultation request has been received. Our team will contact you within 24 hours. You can also reach us directly at (949) 468-3120.
